Your browser doesn't support javascript.
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
Alqahtani, Jaber S; Oyelade, Tope; Aldhahir, Abdulelah M; Mendes, Renata Gonçalves; Alghamdi, Saeed M; Miravitlles, Marc; Mandal, Swapna; Hurst, John R.
  • Alqahtani JS; UCL Respiratory, University College London, London, United Kingdom.
  • Oyelade T; Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.
  • Aldhahir AM; UCL Division of Medicine, London, United Kingdom.
  • Mendes RG; Respiratory Care Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
  • Alghamdi SM; Department of Physical Therapy, Cardiopulmonary Physiotherapy Laboratory, Federal University of São Carlos, São Paulo, Brazil.
  • Miravitlles M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Mandal S; Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Hurst JR; Pneumology Department, Hospital Universitari Vall d´Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Campus; CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
PLoS One ; 16(8): e0255659, 2021.
Article in English | MEDLINE | ID: covidwho-1339417
ABSTRACT

BACKGROUND:

Reports have suggested a reduction in exacerbations of chronic obstructive pulmonary disease (COPD) during the coronavirus disease 2019 (COVID-19) pandemic, particularly hospital admissions for severe exacerbations. However, the magnitude of this reduction varies between studies.

METHOD:

Electronic databases were searched from January 2020 to May 2021. Two independent reviewers screened titles and abstracts and, when necessary, full text to determine if studies met inclusion criteria. A modified version of the Newcastle-Ottawa Scale was used to assess study quality. A narrative summary of eligible studies was synthesised, and meta-analysis was conducted using a random effect model to pool the rate ratio and 95% confidence intervals (95% CI) for hospital admissions. Exacerbation reduction was compared against the COVID-19 Containment and Health Index.

RESULTS:

A total of 13 of 745 studies met the inclusion criteria and were included in this review, with data from nine countries. Nine studies could be included in the meta-analysis. The pooled rate ratio of hospital admissions for COPD exacerbations during the pandemic period was 0.50 (95% CI 0.44-0.57). Findings on the rate of community-treated exacerbations were inconclusive. Three studies reported a significant decrease in the incidence of respiratory viral infections compared with the pre-pandemic period. There was not a significant relationship between exacerbation reduction and the COVID-19 Containment and Health Index (rho = 0.20, p = 0.53).

CONCLUSION:

There was a 50% reduction in admissions for COPD exacerbations during the COVID-19 pandemic period compared to pre-pandemic times, likely associated with a reduction in respiratory viral infections that trigger exacerbations. Future guidelines should consider including recommendations on respiratory virus infection control measures to reduce the burden of COPD exacerbations beyond the pandemic period.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive / COVID-19 / Hospitalization Type of study: Observational study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0255659

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Disease, Chronic Obstructive / COVID-19 / Hospitalization Type of study: Observational study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0255659